Abstract Details

Title Prediction and Characterization of CD56bright NK Cell Expansion during Daclizumab Treatment for Multiple Sclerosis

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 214

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
James Sheridan, PhD (Abbott Labs)	No disclosure on file
Mia Ko, DO	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Jacob S. Elkins, MD	No disclosure on file

��ɫ��